Hedge Fund - Visium Asset Management

Jacob Gottlieb is very bullish on The Spectranetics Corporation (NASDAQ:SPNC) and has increased his fund's stake by more than 300%, as reported in a recent filing with the Securities and Exchange Commission...

Jacob Gottlieb thinks OHR Pharmaceutical Inc (NASDAQ:OHRP) is a good investment and has initiated a new position for his fund, Visium Asset Management.

Visium Asset Management, managed by Jacob Gottlieb, has disclosed a new position in Quotient Ltd (NASDAQ:QTNT). A new filing with the U.S.

Jacob Gottlieb and his fund, Visium Asset Management, have upped their interest in Brookdale Senior Living, Inc.

Visium Asset Management, managed by Jacob Gottlieb, disclosed in an SEC filing that it initiated a 1.6 million position in AMAG Pharmaceuticals Inc.

Visium Asset Management, led by Jacob Gottlieb, has added NephroGenex Inc (NASDAQ:NRX) and Ignyta Inc (OTCBB:RXDX) to its equity portfolio.

Jacob Gottlieb's Visium Asset Management has increased its stake in Intercept Pharmaceuticals Inc (NASDAQ:ICPT), according to an amended filing with the SEC. Gottlieb's fund now holds 1.04 million shares...

The position of Zogenix, Inc.

Jacob Gottlieb's hedge fund, Visium Asset Management, has boosted its position in biotechnology company QLT Inc. (USA) (NASDAQ:QLTI), a new filing with the SEC revealed.